A clinical trial to study the effect of Chitrakadi Lepa and Siddharthakadi Kwath in patients of skin disease w.s.r. to Psoriasis.
Phase 3
Completed
- Conditions
- Health Condition 1: null- Suffering from Psoriasis
- Registration Number
- CTRI/2017/07/008992
- Lead Sponsor
- ational Institute of Ayurveda Jaipur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
Adult male or female with a diagnosis of Psoriasis.
Psoriasis defined as chronic, non contagious disease characterized by inflamed lesions covered with silvery white scabs of dead skin.
Moderate to severe Psoriasis was defined by the same group as BSA > 10 or PASI score > 10.
Exclusion Criteria
Pregnant women and Lactating mothers.
Patients of malignant disorders of skin will be excluded.
Patients of Leprosy & paralysis will be excluded.
Patients not being capable of giving their informed consent or not being capable of following the study conditions.
Patient having major illness like IHD, HTN, MI, TB, COPD, DM.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of patients with a PASI score reduction higher than 75%. <br/ ><br> <br/ ><br>Number of patients with an improvement in mild moderate or severe adverse effects.Timepoint: 12 weeks
- Secondary Outcome Measures
Name Time Method Average time to reach the clinical remission. <br/ ><br>To improve the Quality of life (QoL)Timepoint: 24 weeks